Vivo Capital Fund VIII, L.P.
Related Filers (16)
- Vivo Capital Surplus Fund VIII, L.P. (29)
- Vivo Capital VIII, LLC (26)
- Vivo Opportunity, LLC (14)
- Crinetics Pharmaceuticals, Inc. (9)
- Vivo Opportunity Fund, L.P. (9)
- Terns Pharmaceuticals, Inc. (5)
- Vivo Opportunity Fund Holdings, L.P. (5)
- Bolt Biotherapeutics, Inc. (4)
- Vivo Panda Fund, L.P. (4)
- Vivo Panda, LLC (4)
- IMPEL NEUROPHARMA INC (3)
- Menlo Therapeutics, Inc. (2)
- Vivo Capital, LLC (2)
- Aligos Therapeutics, Inc. (2)
- BioPharmX Corp (1)
- Kadmon Holdings, Inc. (1)
- Show More ...
Other (3)
D/A
Wednesday, 3/18/2015
Exempt (Private) Offering
D/A
Thursday, 2/5/2015
Exempt (Private) Offering
D
Thursday, 12/18/2014
Exempt (Private) Offering
Ownership (27)
4
Wednesday, 11/22/2023
Bolt Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/20/2023
Bolt Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/23/2022
Terns Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/8/2022
Terns Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/16/2022
Terns Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/29/2021
IMPEL NEUROPHARMA INC: Statement of changes in beneficial ownership of securities
4
Monday, 4/26/2021
IMPEL NEUROPHARMA INC: Statement of changes in beneficial ownership of securities
3
Thursday, 4/22/2021
IMPEL NEUROPHARMA INC: Initial statement of beneficial ownership of securities
4
Tuesday, 2/9/2021
Bolt Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/9/2021
Terns Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 2/4/2021
Terns Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 2/4/2021
Bolt Biotherapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 10/20/2020
Aligos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/15/2020
Aligos Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 4/17/2020
Crinetics Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/7/2020
Crinetics Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/11/2020
Crinetics Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/11/2020
Crinetics Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/6/2020
Crinetics Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/31/2020
Crinetics Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/25/2019
Crinetics Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 1/8/2019
Kadmon Holdings, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 7/20/2018
Crinetics Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 7/17/2018
Crinetics Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 1/29/2018
Menlo Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/24/2018
Menlo Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 5/1/2017
BioPharmX Corp: Statement of changes in beneficial ownership of securities